Chargement de votre page…
Depression and anxiety
Par Li B, Jiang Y, Li C et 5 autres.
Contenu en anglais
Vision-threatening diabetic retinopathy (VTDR) poses significant blindness risks and the study aimed to identify the impact of psychological factors on its ocular outcomes.
Ward réunit ces articles dans la même app que vos cartes et vos questions. Un seul compte gratuit pour Ward, Suture, Osler et Prognia.
This retrospective cohort study enrolled 782 VTDR patients from three ophthalmological centers (2018-2021). DR severity was graded using ETDRS criteria. Primary outcomes included tractional retinal detachment (TRD) involving the fovea, neovascular glaucoma (NVG), final best-corrected visual acuity (BCVA) <0.3, and recurrent vitreous hemorrhage (VH). Anxiety and depression were assessed via the hospital anxiety and depression scale (HADS). Univariable and multivariable logistic regression evaluated the associations between HADS scores and ocular outcomes.
After a median follow-up of 24.8 months, depressive symptoms (HADS-D ≥8) were associated with higher rates of BCVA <0.3 (67.8% vs. 57.2%, p = 0.033) and NVG (13.6% vs. 6.9%, p = 0.020). Recurrent VH was more frequent in patients with anxiety (21.0% vs. 10.6%, p = 0.031) or depression (20.3% vs. 10.7%, p = 0.045). Multivariable logistic analysis revealed that each 1-point increase in HADS-D score significantly increased adjusted odds of TRD (aOR = 1.06, 95% CI: 1.01-1.11), BCVA <0.3 (aOR = 1.07, 95% CI: 1.02-1.11), recurrent VH (aOR = 1.09, 95% CI: 1.02-1.17), and NVG (aOR = 1.10, 95% CI: 1.03-1.17; all p < 0.05). There was a consistent positive gradient between HADS severity and adverse outcomes.
Depressive symptoms are independently associated with worse ocular prognoses in VTDR patients. Systematic psychological screening and intervention is essential to mitigate vision deterioration risk in this population.
Publié dans Depression and anxiety. Le résumé est reproduit tel qu’il a été publié et reste l’œuvre de ses auteurs ; lisez l’article complet à la source.
Prognia référence cet article à des fins de documentation et de formation. Il ne constitue pas un avis médical. Lisez toujours l’original et suivez les recommandations en vigueur et les protocoles locaux avant d’agir.
